ROR1 and ROR2 expression in pancreatic cancer
Abstract Background The Wnt receptors ROR1 and ROR2 are generating increased interest as cancer therapeutic targets but remain understudied in pancreatic ductal adenocarcinoma (PDAC). Compared to canonical Wnt/ β-catenin signalling, the role of noncanonical Wnt signalling in PDAC remains largely unk...
Guardado en:
Autores principales: | Dongli Liu, George Sharbeen, Phoebe Phillips, Australian Pancreatic Cancer Genome Initiative, Caroline E. Ford |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/77c1d36dfb864511964d2a94105709b4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cdk5 drives formation of heterogeneous pancreatic neuroendocrine tumors
por: Angela M. Carter, et al.
Publicado: (2021) -
Pentraxin 3 is a stromally-derived biomarker for detection of pancreatic ductal adenocarcinoma
por: Michelle R. Goulart, et al.
Publicado: (2021) -
A novel event-free survival endpoint in locally advanced pancreatic cancer
por: Pascal Hammel, et al.
Publicado: (2021) -
Prognosticating Outcome in Pancreatic Head Cancer With the use of a Machine Learning Algorithm
por: Zarrukh Baig MD, et al.
Publicado: (2021) -
Circulating stromal cells in resectable pancreatic cancer correlates to pathological stage and predicts for poor clinical outcomes
por: Kirby P. Gardner, et al.
Publicado: (2021)